abstract |
The present invention relates to a biomarker, a prediction kit, or a prediction method, the biomarker for predicting whether or not positivity for bacteria is retained without spontaneous negativity for bacteria with no appropriate treatment, as a prognosis after nontuberculous mycobacterium infection by means of metabolites. |